Description
GLP-RT | Product Description
GLP-RT | Introduction
GLP-RT is the Ntegrity Labs catalog designation for retatrutide, also identified in published research as LY3437943. Retatrutide is an investigational single peptide described as an agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. This catalog material is offered strictly for controlled laboratory research. It is not intended for diagnostic, therapeutic, human, or veterinary use.
- Multi-receptor signal-transduction models
- Comparative receptor-pathway response studies
- Controlled in vitro assay development
At a glance: Investigational research peptide · GIPR / GLP-1R / GCGR agonist classification · selectable labeled strengths · Batch-specific documentation
GLP-RT | Molecular Identity & Composition
| Material name | Retatrutide |
|---|---|
| Development code | LY3437943 |
| Research classification | Single-peptide triple receptor agonist |
| Reported receptor targets | GIPR, GLP-1R, and GCGR |
| Labeled quantity | 10 mg |
| Catalog SKU | NTR-RT; each purchasable strength has its own variation SKU |
| Physical form | Confirm against the specific batch record and packaging |
| Purity and identity | Batch-specific results only; review the Third-Party Testing tab |
GLP-RT | Available Strengths
This page is the single GLP-RT catalog record for retatrutide. Choose a labeled strength in the selector above:
- 10 mg
- 20 mg
- 30 mg
- 40 mg
Each strength has its own SKU, inventory status, and batch-documentation relationship. Only released, priced, and stocked strengths can be added to the cart.
Ntegrity Quality & Documentation
Ntegrity Labs treats analytical evidence as batch-specific. A product-level badge does not replace the underlying laboratory report. When approved documentation is available, the testing tab identifies the relevant material, batch, laboratory, methods, test date, and reported results.
- No purity claim is applied across unrelated batches.
- Third-party and group-buy reports retain their original laboratory and customer provenance.
- A report is published only after its product and batch relationship has been reviewed.
Category Overview | Multi-Receptor Research Materials
This category covers research materials investigated for activity across more than one receptor pathway. Multi-target materials may be used in controlled laboratory models designed to compare integrated signaling with single-pathway responses.
Category placement describes research context only. It is not a statement of clinical performance, safety, or intended therapeutic use.
GLP-RT | Research Context & Applications
Peer-reviewed and registered research describes retatrutide as a GIP, GLP-1, and glucagon receptor agonist. Relevant laboratory models may examine receptor activation, pathway interaction, concentration-response behavior, and assay selectivity under controlled conditions.
Published clinical studies describe the investigational molecule. They do not establish an intended use for the Ntegrity Labs research material sold on this page.
Research Use Disclaimer
This material is intended exclusively for laboratory research and analytical work. It is not for human or veterinary use and is not intended for diagnosis, treatment, cure, mitigation, or prevention of disease. Purchasers are responsible for lawful acquisition, qualified handling, appropriate storage, and use within suitable research facilities.
